What are the current guidelines for cervical cancer screening via Pap tests and HPV testing?

• A. Ages 21–29: Pap every 3 years. Ages 30–65: co-testing (Pap + HPV) every 5 years or Pap alone every 3 years. Stop at 65 with adequate prior screening and no risk factors; adjust for risk.
• B. Ages 21–29: Pap every 5 years; Ages 30–65: HPV only testing every 5 years.
• C. Annual Pap for all ages.
• D. Stop screening at 50 regardless of risk.

Answer: (A)

Screening for cervical cancer is tailored by age and combines Pap cytology with HPV testing in ways that balance sensitivity, specificity, and practical intervals. For people aged 21–29, Pap cytology every 3 years is recommended because HPV infections are common but often transient in this group, and adding HPV testing at this age doesn’t improve outcomes enough to justify routine use. In people aged 30–65, you have two acceptable paths: either co-testing with Pap plus HPV every 5 years, or Pap cytology alone every 3 years. HPV-only screening is not the standard approach in this age range because combining tests or using cytology alone provides proven protection while avoiding over-treatment.

Stopping screening at age 65 is appropriate if there has been adequate prior screening and no high-risk factors; in other words, a history of several negative results within the recommended intervals and no new risk factors allows cessation. If there are ongoing risk factors or an inadequate prior screening history, continued screening is advised.